Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kim Papp

Showing results (1-10 of 137) with videos related to

Pageof 14
Sort By:
Current Medical Research and Opinion|August 20, 2010
Clinical development of onercept, a tumor necrosis factor binding protein, in psoriasisKim Papp
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|October 21, 2015
Selective Phosphodiesterase Inhibitors for Psoriasis: Focus on ApremilastMelinda Gooderham, Kim Papp
Journal of the American Academy of Dermatology|October 17, 2015
The psychosocial impact of hidradenitis suppurativaMelinda Gooderham, Kim Papp
Current Problems in Dermatology|November 14, 2017
Clinical Trial and Registry DataMelinda Gooderham, Kim Papp
Journal of Cutaneous Medicine and Surgery|April 16, 2013
Examining the risk of cardiovascular disease in patients with psoriasis: a critical reviewKim Papp, Yves Poulin, Andrew Vieira
Journal of Cutaneous Medicine and Surgery|December 2, 2017
Diagnosis and Management of Conjunctivitis for the DermatologistMelinda Gooderham, Julian McDonald, Kim Papp
Journal of Cutaneous Medicine and Surgery|October 6, 2009
Adalimumab in the treatment of psoriasis: pooled efficacy and safety results from three pivotal studiesKim Papp, Martin Okun, Ronald Vender
Dermatologic Therapy|December 17, 2008
Long-term efficacy of up to 15 months' efalizumab therapy in patients with moderate-to-severe chronic plaque psoriasisDarryl P Toth, Kim Papp, David Gratton
Expert Review of Clinical Pharmacology|October 4, 2016
Ixekizumab for treatment of adults with moderate-to-severe plaque psoriasis and psoriatic arthritisTrang T Vu, Melinda Gooderham, Kim Papp
Skin Therapy Letter|July 25, 2019
A Closer Look at the Data Regarding Suicidal Ideation and Behavior in Psoriasis Patients: The Case of BrodalumabFabian Rodriguez-Bolanos, Melinda Gooderham, Kim Papp
Pageof 14

Showing results (1-10 of 137) with videos related to

Sort By:
Pageof 14
Current Medical Research and Opinion|August 20, 2010
Clinical development of onercept, a tumor necrosis factor binding protein, in psoriasisKim Papp
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|October 21, 2015
Selective Phosphodiesterase Inhibitors for Psoriasis: Focus on ApremilastMelinda Gooderham, Kim Papp
Journal of the American Academy of Dermatology|October 17, 2015
The psychosocial impact of hidradenitis suppurativaMelinda Gooderham, Kim Papp
Current Problems in Dermatology|November 14, 2017
Clinical Trial and Registry DataMelinda Gooderham, Kim Papp
Journal of Cutaneous Medicine and Surgery|April 16, 2013
Examining the risk of cardiovascular disease in patients with psoriasis: a critical reviewKim Papp, Yves Poulin, Andrew Vieira
Journal of Cutaneous Medicine and Surgery|December 2, 2017
Diagnosis and Management of Conjunctivitis for the DermatologistMelinda Gooderham, Julian McDonald, Kim Papp
Journal of Cutaneous Medicine and Surgery|October 6, 2009
Adalimumab in the treatment of psoriasis: pooled efficacy and safety results from three pivotal studiesKim Papp, Martin Okun, Ronald Vender
Dermatologic Therapy|December 17, 2008
Long-term efficacy of up to 15 months' efalizumab therapy in patients with moderate-to-severe chronic plaque psoriasisDarryl P Toth, Kim Papp, David Gratton
Expert Review of Clinical Pharmacology|October 4, 2016
Ixekizumab for treatment of adults with moderate-to-severe plaque psoriasis and psoriatic arthritisTrang T Vu, Melinda Gooderham, Kim Papp
Skin Therapy Letter|July 25, 2019
A Closer Look at the Data Regarding Suicidal Ideation and Behavior in Psoriasis Patients: The Case of BrodalumabFabian Rodriguez-Bolanos, Melinda Gooderham, Kim Papp
Pageof 14